Home > Drug Search >
  • company_query: Advaxis
  •   > 
Drug Filter
Category:
chemistry (6) biology (25)
Status:
Approved (6) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (7) Phase Ⅰ (11)
Clinical Stage:
Pending (2) Active (21) Discontinued (2)
Bio-Type:
Cell therapy (3) Vaccine (15) Blood extraction (1) Recombinant coagulation factor (1) Whole antibody (2) Fusion protein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Breast cancer (3) Crohn's disease (1) Cutaneous T cell lymphoma (CTCL) (1) Iron-deficiency anemia (1) Cholera (1) Diarrhea (1) Duchenne muscular dystrophy (DMD) (1) Endometriosis (1) Anal cancer (1) Gastric cancer (1) Hepatocellular carcinoma (HCC) (1) Hyperlipidemia (1) Melanoma (2) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (1) Factor X deficiency (1) Osteosarcoma (1) Pancreatic cancer (2) Prostate cancer (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Oropharyngeal cancer (1) Rectal fistula (1) Solid tumours (1) Chikungunya virus infections (1) Ulcerative colitis (1) Head and neck cancer (2) Ankylosing Spondylitis (AS) (1) Anthrax (1) Stroke (1) Cervical carcinoma (1) Sarcoma (1) Malaria (1) Hemophilia B (1) Congenital factor VII deficiency (1) Autoimmune diseases (1) Merkel cell carcinoma (1) Clostridial infection (1) Plaque psoriasis (1) Bleeding (1) Enterovirus infection (1) Respiratory syncytial virus infection (1) Dengue fever (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top